ProQR Therapeutics NV (PRQR)
1.48
+0.01
(+0.68%)
USD |
NASDAQ |
Feb 10, 16:00
1.485
0.00 (0.00%)
Pre-Market: 20:00
ProQR Therapeutics EPS Diluted (Quarterly) : -0.1221 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.376 |
| argenx SE | -- |
| Pharming Group NV | 0.109 |
| Pharvaris NV | -0.6971 |
| NewAmsterdam Pharma Co. NV | -0.6051 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.86M |
| Revenue (Quarterly) | 3.368M |
| Total Expenses (Quarterly) | 16.23M |
| Enterprise Value | 47.47M |
| Gross Profit Margin (Quarterly) | 76.72% |
| Profit Margin (Quarterly) | -381.9% |
| Earnings Yield | -30.86% |
| Normalized Earnings Yield | -30.99 |